Psoriasis: ESPRIT: Post-marketing, Observational Study of Humira® (adalimumab) in Patients With Chronic Plaque Psoriasis
contact information:
Nicole Bisby or visit www.clinicaltrails.gov (Reference #NCT00799877)
202.741.2437 < back to clinical trials list
The purpose of this 10-year observationaltion trial is to evaluate the long-term safety of Humira® in psoriasis patients. Patients seen in the MFA Psoriasis Clinic may be eligible to participate in this study.
contact information:
Nicole Bisby or visit www.clinicaltrails.gov (Reference #NCT00799877)
202.741.2437 < back to clinical trials list
ABOUT SSL CERTIFICATES |